Anti-obesity Drugs Market Growth Trend Analysis US$ 29.34 Min. order: 1 piece ★★★★★ 4.1 (85 reviews) Sold : Login>>
Novo outlines new late-stage study of obesity drug CagriSema US$ 21.30 Min. order: 1 piece ★★★★★ 4.7 (233 reviews) Sold : Login>>
CagriSema Held the Muscle. That's the Whole Game Now US$ 21.53 Min. order: 1 piece ★★★★★ 4.2 (68 reviews) Sold : Login>>
PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 29.13 Min. order: 1 piece ★★★★★ 4.5 (171 reviews) Sold : Login>>
Outlook for obesity in 2025: more than a transition year US$ 24.68 Min. order: 1 piece ★★★★★ 4.6 (227 reviews) Sold : Login>>